throbber
W ORLD INTELLECTU.1
`Intern
`PCT
`INTERNATIONAL APPLICATION PUBLISHED l
`
`W0
`
`9604289A1
`
`(51) International Patent Classification 6 :
`
`(11) International Publication Number:
`
`WO 96/04289
`
`C07F 15/00, C08F 4/80, 32/04, 32/08
`
`(43) International Publication Date:
`
`15 February 1996 (15.02.96)
`
`(21) International Application Number:
`
`PCT/US95/09655
`
`(22) International Filing Date:
`
`28 July 1995 (28.07.95)
`
`(30) Priority Data:
`08/282,826
`08/282,827
`
`29 July 1994 (29.07.94)
`29 July 1994 (29.07.94)
`
`US
`US
`
`(81) Designated States: AM, AT, AU, BB, BG, BR, BY, CA, CH,
`CN, CZ, DE, DK, EE, ES, FI, GB, GE, HU. IS, JP, KE,
`KG, KP, KR, KZ, LK, LR, LT, LU, LV, MD, MG, MN,
`MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, 80, SI, SK,
`TJ, TM, TT, UA, U0, U2, VN, European patent (AT, BE,
`CH, DE, DK, ES, FR, GB, GR, IE, IT, LU, MC, NL, PT,
`SE), OAPI patent (BF, BJ, CF, CG, CI, CM, GA, GN, ML,
`MR, NE, SN, TD, TG), ARIPO patent (KE, MW, SD, 82,
`UG).
`
`(71) Applicant: CALIFORNIA INSTITUTE OF TECHNOLOGY
`[US/US]; 1201 East California Boulevard, Pasadena, CA
`91125 (US).
`
`Published
`With international search report.
`
`(72) Inventors: GRUBBS, Robert, H.; 1700 Spruce Street, South
`Pasadena, CA 91030 (US).
`NGUYEN, SonBinh, T.;
`Mosher-Jorgensen House #103, Pasadena, CA 91125 (US).
`JOHNSON, Lynda, K.; Apartment A3, 601 Jones Ferry
`Road, Carrboro, NC 27510 (US). HILLMYER, Marc, A.;
`703 East California Boulevard #1, Pasadena, CA 91106
`(US).
`FU, Gregory, C.;
`100 Memorial Drive #218C,
`Cambridge, MA 02142 (US).
`
`(74) Agents: COLEMAN, James, Patricia et al.; Limbach 8:
`Limbach, 2001 Ferry Building, San Francisco, CA 94111-
`4262 (US).
`
`either isopropyl, isobutyl, sec-butyl, neopentyl, neophenyl, cyclopentyl or cyclohexyl.
`
`(54) Title: HIGH ACTIVITY RUIHENIUM OR OSMIUM METAL CARBENE COMPLEXES FOR OLEFIN METATHESIS REAC-
`TIONS AND SYNTHESIS THEREOF
`
`(57) Abstract
`
`Ruthenium and osmium carbene compounds
`which are stable in the presence of a variety of
`functional groups and which can be used to catalyze
`olefin metathesis reactions are discussed. Methods
`for synthesizing these carbene compounds are also
`disclosed. Specifically, the present invention relates
`to carbene compounds of formula (I) wherein: M
`is Os or Ru; R and R1 are independently selected from hydrogen; C2—C20 alkenyl, C2-C20 alkynyl, C1-Czo alkyl, aryl, C1-C20 carboxylate,
`C2-Czo alkoxy, C2-Czo alkenyloxy, C2-Czo alkynyloxy, aryloxy, C2-Czo alkoxycarbonyl, C1-Czo alkylthio, C1-C20 alkylsulfonyl or C1-Czo
`alkylsulfinyl; each optionally substituted with C1-C5 alkyl. halogen. C1-C5 alkoxy or with a phenyl group optionally substituted with halogen,
`C1-C5 alkyl or C1-C5 alkoxy; X and X1 are independently selected from any anionic ligand; and L and Ll are each triallcyl phosphine
`ligands where at least one of the alkyl groups on the phosphine is a secondary alkyl or a cycloalkyl. In a preferred embodiment, all of the
`alkyl groups of the trialkyl phosphine are either a secondary alkyl or a cycloalkyl. In a more preferred embodiment, the alkyl groups are
`
`(I)
`
`

`

`FOR THE PURPOSES OF INFORMATION ONLY
`
`Codes used to identify States party to the PCI‘ on the front pages of pamphlets publishing international
`applications under the PCI‘.
`
`Viet Nam
`
`United Kingdom
`Georgia
`Guinea
`Greece
`Hans-Iv
`Ireland
`Italy
`Japan
`Kenya
`Kyrgyatan
`Democratic People's Republic
`of Korea
`Republic of Korea
`Kazakhstan
`Liechtenstein
`Sri Lanka
`Luxembourg
`Latvia
`Monaco
`Republic of Moldova
`
`AT
`AU
`BB
`BE
`BF
`BG
`3.]
`BR
`BY
`CA
`CF
`CG
`CH
`CI
`CM
`CN
`CS
`CZ
`DE
`
`Austria
`Auau‘alia
`Barbados
`Belgium
`Burkina Faso
`Bulgaria
`Benin
`Brazil
`Belarus
`Canada
`Central African Republic
`Congo
`Switzerland
`COte d'Ivoire
`Cameroon
`China
`Czechoslovakia
`Czech Republic
`Germany
`
`Mauritania
`Malawi
`Niger
`Netherlands
`Norway
`New Zealand
`Poland
`Portugal
`Romania
`Russian Federation
`Sudan
`Sweden
`Slovenia
`Slovakia
`Senegal
`Chad
`Togo
`Tajikistan
`Trinidad and Tobago
`Ukraine
`United Statea of America
`Uzbekistan
`
`

`

`WO 96/04289
`
`PCT/US95/09655
`
`HIGH ACTIVITY RUTHENIUM OR OSMIUM METAL CARBENE
`COMPLEXES FOR OLEFIN METATHESIS REACTIONS
`AND SYNTHESIS THEREOF
`
`The US. Government has certain rights in this invention pursuant to Grant No. CHE-8922072
`awarded by the National Science Foundation.
`
`W
`
`IO
`
`15
`
`20
`
`W
`
`This invention relates to highly active and stable ruthenium or osmium metal carbene complex
`compounds, synthesis methods thereof and their use as catalysts in olefin metathesis reactions.
`
`During the past two decades, research efforts have enabled an in-depth understanding of the olefin
`metathesis reaction as catalyzed by early transition metal complexes.
`In contrast, the nature of the
`intermediates and the reaction mechanism for Group VIII transition metal catalysts has remained elusive.
`In particular, the oxidation states and ligation of the ruthenium and osmium metathesis intermediates are
`not known.
`
`Many ruthenium and osmium metal carbenes have been reported in the literature (for example, see
`Burrell, A.K., Clark, G.R., Rickard, C.E.F., Roper, W.R., Wright, A.H., J. Chem. Soc., Dalton Trans.,
`
`1991, Issue 1, pp. 609-614). However, the discrete ruthenium and osmium carbene complexes isolated to
`
`date do not exhibit metathesis activity to unstrained olefins.
`Academic Press: London, 1983).
`
`(Ivin, Olefin Metathesis pp. 34-36,
`
`SUMMARY OF THE INVENTION
`
`The present invention relates to ruthenium or osmium carbene compounds which are stable in the
`
`presence of a variety of functional groups and which can be used to catalyze olefin metathesis reactions
`on unstrained cyclic and acyclic olefins.
`
`Specifically, the present invention relates to carbene compounds of the formula
`
`1
`
`'
`X\| _ a
`x‘/T— \FI
`
`L1
`
`25
`
`wherein:
`
`M is Os or Ru;
`R and R1 are independently selected from hydrogen or a hydrocarbon selected from the group
`consisting of C2-C20 alkenyl, C2-C20 alkynyl, C1-C20 alkyl, aryl, C1-C20 carboxylate, C2-C20
`alkoxy, CZ'CZO alkenyloxy, C2-C20 alkynyloxy, aryloxy, C2-C20 alkoxycarbonyl, C1-C20
`alkylthio, CI'CZO alkylsulfonyl and C1-C20 alkylsulfinyl;
`X and X1 are independently selected from any anionic ligand; and
`L and L] are independently selected from any neutral electron donor, preferably phosphine,
`sulfonated phosphine, phosphite, phosphinite, phosphonite, arsine, stibine, ether, amine, amide,
`
`sulfoxide, carboxyl, nitrosyl, pyridine and thioether, most preferably trialkylphosphine ligands
`where at least one of the alkyl groups is a secondary alkyl or a cycloalkyl.
`
`In a preferred embodiment, the hydrocarbon is selected from the group consisting of C1-C5 alkyl,
`halogen, C1-C5 alkoxy and a phenyl group. The hydrocarbon also may be substituted with a C1-C5
`alkyl halogen, CI'CS alkoxy, or a phenyl group.
`In an alternative embodiment, the phenyl group is optionally substituted with halogen, Cl-C5 alkyl
`or C1-C5 alkoxy.
`
`30
`
`35
`
`40
`
`SUBSTITUTE SHEET (RULE 26)
`
`

`

`WO 96104289
`
`PCT/U895109655
`
`In a preferred embodiment, all of the alkyl groups of the trialkyl phosphine are either a secondary
`
`In a more preferred embodiment, the alkyl groups are either isopropyl, isobutyl,
`alkyl or a cycloalkyl.
`sec-butyl, neopentyl, neophenyl, cyclopentyl or cyclohexyl.
`Carbene compounds where L and L1 ligands are alkyl phosphines where the carbon backbone of at
`least one alkyl group of the alkyl phosphine is a secondary alkyl or cycloalkyl have been found to
`
`possess higher metathesis activity, enabling these compounds to coordinate to and catalyze metathesis
`reactions between all types of olefins. By contrast, previous metathesis catalysts were only able to
`
`catalyze metathesis reactions involving highly strained olefins. As a result, a broad array of metathesis
`
`10
`
`reactions are enabled using the carbene compounds of the present invention that cannot be performed
`using less reactive catalysts.
`
`15
`
`20
`
`The present invention also relates to the synthesis of ruthenium or osmium carbene compounds
`which can be used to catalyze olefin metathesis reactions.
`
`Certain of the carbene compounds of the present invention are the only Ru and Cs carbene
`complexes known to date in which the metal is formally in the +2 oxidation state, have an electron count
`
`of 16, and are pentacoordinate. Unlike most metathesis catalysts presently known which are poisoned by
`functional groups, the carbene compounds of the present invention are stable in the presence of alcohol,
`
`thiol, ketone, aldehyde, ester, ether, amine, amide, nitro acid, carboxylic acid, disulfide, carbonate,
`
`carboalkoxy and halogen functional groups and may therefore be used in protic or aqueous solvent
`systems.
`
`In another embodiment of the present invention, the carbene compounds can be in the form
`wherein 2, 3 or 4 of the moieties X, X], L, and L] can be taken together to form a chelating
`multidentate ligand.
`In one aspect of this embodiment, X, L, and L1 can be taken together to form a
`cyclopentadienyl, indenyl, or fluorenyl moiety.
`
`25
`
`The ruthenium or osmium carbene compounds may be prepared by reacting a compound of the
`formula (XXIMLnLIm)p,
`in the presence of solvent, with a cyclopropene of the formula
`
`R2
`
`R3
`
`wherein:
`
`M, X, X1, L, and LI have the same meaning as
`indicated above;
`
`it and m are independently 0-4, provided n+m= 2, 3 or 4;
`
`30
`
`35
`
`40
`
`p is an integer equal to or greater than I; and
`R2 and R3 are independently selected from hydrogen or a hydrocarbon selected from the group
`consisting of CZ‘CIS alkyl, C2-C18 alkenyl, C2-C18 alkynyl, C2-C18 alkoxycarbonyl, aryl, C1-
`C18 carboxylate, C1-C18 alkenyloxy, C2-C18 alkynyloxy, C1-C18 alkoxy, aryloxy, C1-C1 8
`alkylthio, CI'CIS alkylsulfonyl or C1-C18 alkylsulfmyl;
`in a preferred embodiment the hydrocarbon is substituted with CI'CS alkyl, halogen, C1-C5
`alkoxy or with a phenyl group.
`
`In a preferred embodiment the phenyl group is substituted with halogen, C1-C5 alkyl or Cl’
`C5 alkoxy.
`
`In one embodiment of the process, X, L, and L1 are taken together to form a moiety
`selected from the group consisting of cyclopentadienyl, indenyl or fluorenyl, each optionally
`substituted with hydrogen; C2-C20 alkenyl, C2-C20 alkynyl, C1-C20 alkyl, aryl, C1-C20
`carboxylate, C1-C20 alkoxy, C2-C20 alkenyloxy, C2-C20 alkynyloxy, aryloxy, C2-C20
`-2-
`
`SUBSTITUTE SHEET (RULE 26)
`
`

`

`
`
`WO 96/04289
`
`PCTIU 895/09655
`
`alkoxycarbonyl, C1-C20 alkylthio, C1-C20 alkylsulfonyl, C1-C20 alkylsulfinyl; each optionally
`substituted with C1—C5 alkyl, halogen, C1-C5 alkoxy or with a phenyl group optionally substituted
`with halogen, C1-C5 alkyl or C1-C5 alkoxy.
`A further method of preparing the compounds of this invention comprises reacting
`compound of the formula (XXIMLnle)
`formula
`
`p in the presence of solvent with a phosphorane of the
`
`R‘\—/R
`“5 /
`\R.
`R6
`
`“I" P_C
`
`wherein:
`
`M, X, X‘, L, L'. n, m, p, R, and RI have the same meaning as indicated above; and
`R4, R5 and R6 are independently selected from aryl, Cl-C6 alkyl, C1-C6 alkoxy or phenoxy, each
`optionally substituted with halogen, C1-C3 alkyl, C1-C3 alkoxy, or with a phenyl group
`optionally substituted with halogen, C1-C5 alkyl or C1-C5 alkoxy.
`The present invention also pertains to a preferred method of preparing the aforementioned
`ruthenium and osmium compounds comprising reacting [(Ar) MX Xllz dimer complex with two
`equivalents of a phosphine ligand and a cyclopropene of the formula
`
`R2
`
`R3
`
`in a one step synthesis wherein:
`M, X and X1 have the same meaning as indicated above;
`Ar is an aromatic compound, preferably a di-, tri-, tetra- or hexa- substituted benzene, most
`preferably selected from benzene, toluene, xylene, cymene, tetramethylbenzene or
`hexamethylbenzene; and phosphine ligand is represented by the formula PR7R8R9 wherein
`R7, R8 and R9 are independently selected from substituted and unsubstituted C1-C10 alkyl,
`secondary alkyl, cycloalkyl and aryl.
`
`Another embodiment of the present invenLtion comprises preparing compounds of Formula ll
`
`5
`
`10
`
`15
`
`20
`
`L | M
`
`:
`
`lL
`
`‘
`
`Y\
`x/
`
`.3-
`
`SUBSTITUTE SHEET (RULE 25)
`
`and Formula 11]
`
`

`

`WO 96/04289
`
`PCT/US95I09655
`
`from compound of Formula I
`
`1
`
`X\I\|»=c’R
`x
`|1
`R
`
`1/
`
`\
`
`L
`
`5
`
`comprising reacting said compound of Formula 1, in the presence of solvent, with compound of the
`formula MIY wherein:
`M, R, R1 X, X], L, and L1 have the same meaning as indicated above, and wherein:
`(l) M1 is Li, Na or K, and Y is Cl'clo alkoxide, arylalkoxide, amide or arylamide each
`optionally substituted with C1-Clo alkyl or halogen, diaryloxide; or
`(2) MI is Na or Ag, and Y is Cl04, PF6, BF4, SbF6, halogen. B(a.ryl)4, C1-Clo alkyl sulfonate
`or aryl sulfonate.
`
`Another embodiment of the present invention is a method of preparing compounds of structures of
`Formula IV
`
`10
`
`and Formula V
`
`from a compound of Formula I
`
`-4-
`
`SUBSTITUTE SHEET (RULE 26)
`
`

`

`WO 96/04289
`
`PCT/US95/09655
`
`comprising reacting a compound of
`
`5
`
`10
`
`Formula I, in the presence of
`solvent, with L2 wherein:
`M, R, R1, X, and XI have the same meaning as indicated above; and
`L, L1, and L2 are independently selected from any neutral electron donor, preferably secondary
`alkyl or cycloalkyl phosphine ligands.
`
`The compounds of Formulae II, Ill, IV, and V are species of, i.e., fall within, the scope of
`compounds of Formula I.
`In other words, certain compounds of Formula I are used to form other
`compounds of Formula I by ligand exchange.
`In this case, X and X1 in Formula I are other than the Y
`in Formulae II and III that replaces X. Similarly, L and L] in Formula I are other than the L2 in
`Formulae IV and V.
`If any 2 or 3 of X, X', L, and L1 form a multidentate ligand of Formula I, only
`the remaining ligand moieties would be available for ligand replacement.
`The reference above to X, X], L, and L1 having the same meaning as indicated above refers to
`these moieties individually and taken together to form a multidentate ligand as described above.
`
`l5
`
`The present invention also relates to metathesis coupling of olefins catalyzed by the carbene
`compounds of the present invention. The high level metathesis activity of the ruthenium and osmium
`
`carbene compounds of the present invention enable these compounds to coordinate with and catalyze
`metathesis reactions between all types of olefins. By contrast, previous non-carbene ruthenium and
`
`osmium metathesis catalysts are only able to catalyze metathesis reactions involving highly strained
`
`20
`
`olefins. As a result, a broad array of metathesis reactions are enabled using the carbene compounds of
`the present invention that cannot be performed using less reactive catalysts.
`Examples of metathesis olefin coupling reactions enabled by the ruthenium and osmium carbene
`
`compounds of the present invention include, but are not limited to, ring-opening metathesis
`
`polymerization of strained and unstrained cyclic olefins, ring closing metathesis of acyclic dienes, cross
`
`25
`
`metathesis reactions involving at least one acyclic or unstrained cyclic olefin and depolymerization of
`olefinic polymers.
`
`The present invention relates to new highly active and stable ruthenium or osmium carbene
`
`compounds which can be used to catalyze olefin metathesis reactions.
`
`30
`
`Specifically, the present invention relates to carbene compounds of the formula
`
`DETAILED DESCRIPTION
`
`L
`x\ l _ R‘
`‘/M c\
`l
`L1
`
`R
`
`x
`
`wherein:
`
`M is Os or Ru;
`R and R1 are independently selected from hydrogen; C2-C20 alkenyl, C2-C20 alkynyl, Cl'CZO
`alkyl, aryl, C1-C20 carboxylate, C2-C20 alkoxy, C2-C20 alkenyloxy, C2-C20 alkynyloxy, aryloxy,
`C2-C20 alkoxycarbonyl, CI’CZO alkylthio, C1-C20 alkylsulfonyl or C1-C20 alkylsulfinyl; each
`
`35
`
`-5-
`
`SUBSTITUTE SHEET (RULE 26)
`
`

`

`WO 96104289
`
`PCT/US95/09655
`
`optionally substituted with C1-C5 alkyl, halogen, C1-C5 alkoxy or with a phenyl group optionally
`substituted with halogen, C1-C5 alkyl or C1-C5 alkoxy;
`X and X1 are independently selected from any anionic ligand; and
`L and L1 are independently selected from any neutral electron donor, preferably phosphine,
`sulfonated phosphine, phosphite, phosphinite, phosphonite, arsine, stibine, ether, amine, amide,
`
`sulfoxide, carboxyl, nitrosyl, pyridine and thioether, most preferably trialkylphosphine ligands
`where at least one of the alkyl groups is a secondary alkyl or a cycloalkyl.
`In a preferred embodiment, all of the alkyl groups of the trialkyl phosphine are either a secondary
`alkyl or a cycloalkyl.
`In a more preferred embodiment, the alkyl groups are either isopropyl, isobutyl,
`sec-butyl, neopentyl, neophenyl, cyclopentyl or cyclohexyl.
`
`The high level metathesis activity of the carbene compounds of the present invention is observed
`when L and L1 are alkyl phosphines where the carbon backbone of at least one alkyl group of the alkyl
`phosphine is a secondary alkyl or cycloalkyl. Substitution of the secondary alkyl and cycloalkyl with
`additional carbon moieties and/or other functional groups are intended to be included with the terms
`secondary alkyl and cycloalkyl.
`
`10
`
`15
`
`The ruthenium or osmium carbene complexes of the invention are useful for catalyzing olefin
`metathesis reactions. The propagating carbene moiety has been found to be stable and continues to
`
`polymerize additional aliquots of monomer for a period after the original amount of monomer has been
`
`20
`
`consumed. The propagating carbene moiety ha also been found to be stable in the presence of alcohol,
`thiol, ketone, aldehyde, ester. ether, amine, amide, nitro acid, carboxylic acid, disulfide, carbonate,
`
`carboalkoxy and halogen functional groups. Aspects of this invention include the metal carbene
`
`compounds, methods for their synthesis, as well as their use as catalysts in a wide variety of olefin
`metathesis reactions.
`
`25
`
`The intermediate compounds (X)(1MLnLl
`prepared by standard known methods.
`
`m)p are either available commercially or can be
`
`30
`
`35
`
`40
`
`The phosphorane and cyclopropene reactants used in the present invention may be prepared in
`
`accordance with the following respective references. Schmidbaur, H., et al., Phosphorus and Sulfur, Vol.
`
`18, pp. 167-170 (1983); Carter, F.L., Frampton, V.L., Chemical Reviews Vol. 64, No. 5 (1964), which
`are incorporated herein by reference.
`
`The present invention also relates to metathesis coupling of olefins catalyzed by the carbene
`
`compounds of the present invention. The high level metathesis activity of the ruthenium or osmium
`
`carbene compounds of the present invention cause these compounds to coordinate with and catalyze
`metathesis reactions between all types of olefins. By contrast, previous non-carbene ruthenium or
`
`osmium metathesis catalysts are only able to catalyze metathesis reactions involving strained olefins. As
`
`a result, a broad array of metathesis reactions are enabled using the carbene compounds of the present
`invention that cannot be performed using less reactive catalysts.
`
`Examples of reactions enabled by the ruthenium and osmium carbene compounds of the present
`invention include, but are not limited to, ring-opening metathesis polymerization of strained and
`
`unstrained cyclic olefins, ring closing metathesis of acyclic dienes, cross metathesis reactions involving at
`least one acyclic or unstrained cyclic olefin and depolymerization of olefinic polymers.
`The carbene compounds disclosed in the present invention, as well as those disclosed in US. Serial
`
`No. 863,606, filed April 3, 1992, are the only Ru and Os carbene complexes known to date in which the
`
`metal is formally in the +2 oxidation state (the carbene fragment is considered to be neutral), have an
`
`45
`
`electron count of 16, and are pentacoordinate. Unlike most metathesis catalysts presently known which
`are poisoned by functional groups, the carbene compounds of the present invention are stable in the
`
`presence of a wide variety of functional groups including alcohol, thiol, ketone, aldehyde, ester, ether,
`
`amine, amide, nitro acid, carboxylic acid, disulfide, carbonate, carboalkoxy acid, carboxylic acid,
`
`disulfide. carbonate. isocyanate, carbodiimide carboalkoxy and halogen functional groups. As a result of
`
`-6-
`
`SUBSTITUTE SHEET (RULE 26)
`
`

`

`WO 96/04289
`
`PCT/US95/09655
`
`their stability in the presence of functional groups. these catalysts may be employed in protic and aqueous
`solvents as well as mixtures of protic, aqueous. and/or organic solvents.
`
`With regard to compounds of Formula I:
`
`alkenyl can include vinyl, 1-propenyl, 2-propenyl; 3-propenyl and the different butenyl, pentenyl
`
`and hexenyl isomers, 1.3-hexadienyl and 2,4,6-heptatrienyl, and cycloalkcnyl;
`
`alkenyloxy can include H2C=CHCH20. (CH3)2C=CHCH20, (CH3)CH=CHCH20,
`CH3CH=CHCH20, (CH3)CH=C(CH3)CH20 and CH2=CHCH2CH20;
`alkoxide can include methoxide. t-butoxide and phenoxide;
`
`10
`
`alkoxy can include methoxy, ethoxy, n-propyloxy, isopropyloxy and the different butoxy, pentoxy
`and hexyloxy isomers;
`
`cycloalkoxy can include cyclopentyloxy and cyclohexyloxy;
`
`15
`
`20
`
`alkoxyalkyl can include CH3OCH2, CH3OCH2CH2, CH3CH20CH2, CH3CH2CH2CH20CH2 and
`CH3CH20CH2CH2; and
`alkoxycarbonyl can include CH30C(=O); CH3CH20C(=O), CH3CH2CH20C(=O),
`(CH3)2CHOC(=O) and the different butoxy-, pentoxy- or hexyloxycarbonyl isomers;
`alkyl can include methyl, ethyl, n-propyl, i-propyl, or the several butyl, pentyl or hexyl isomers
`and primary, secondary and cycloalkyl isomers;
`
`alkylsulfinyl can include CH3SO, CH3CH2SO, CH3CH2CH2SO, (CH3)2CHSO and the different
`butylsulfinyl, pentylsulflnyl and hexylsulfinyl isomers;
`
`alkylsulfonyl can include CH3SOZ, CH3CH2802, CH3CH2CHZSOZ, (CH3)2CH802 and the
`different butylsulfonyl, pentylsulfonyl and hexylsulfonyl isomers;
`alkylthio can include, methylthio, ethylthio, and the several propylthio, butylthio, pentylthio and
`hexylthio isomers;
`
`25
`
`alkynyl can include ethynyl, l-propynyl, 3-propynyl and the several butynyl, pentynyl and hexynyl
`isomers, 2,7-octadiynyl and 2,5,8-decatriynyl;
`
`30
`
`35
`
`40
`
`45
`
`alkynyloxy can include HC=CCH20, CH3C=CCH20 and CH3C=CCH20CH20;
`amide can include HC(=O)N(CH3)2 and (CH3)C(=O)N(CH3)2;
`amine can include tricyclohexylamine, triisopropylamine and trineopentylamine;
`
`arsine can include triphenylarsine,tricyclohexylarsine and triisopropylarsine;
`
`aryl can include phenyl, p-tolyl and p-fluorophenyl;
`
`carboxylate can include CH3C02CH3CH2C02, C6H5C02, (C6H5)CH2COZ;
`cycloalkenyl can include cyclopentenyl and cyclohexenyl.
`
`cycloalkyl can include cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl;
`diketonates can include acetylacetonate and 2,4-hexanedionatc;
`
`ether can include (CH3)3CCH20CH2CH3, THF, (CH3)3COC(CH3)3, CH30CH2CH20CH3, and
`CH3OC6H5;
`'
`phosphine can include triphenylphosphine, tricyclohexylphosphine, triisopropylphosphine,
`trineopentylphosphine and methyldiphenylphosphine;
`
`phosphinite can include triphenylphosphinite, tricyclohexylphosphinite, triisopropylphosphinite, and
`
`methyldiphenylphosphinite;
`
`phosphite can include triphenylphosphite, tricyclohexylphosphite, tri-t—butylphosphite,
`
`triisopropylphosphite and methyldiphenylphosphite;
`secondary alkyl includes ligands of the general formula -CHRRl where R and R1 are carbon
`moieties;
`
`stibinc can include triphenylstibine, tricyclohexylstibine and trimethylstibine;
`sulfonate can include trifluoromethanesulfonate, tosylate, and mesylate;
`
`sulfoxide can include CH3S(=O)CH3, (C6H5)280; and
`thioether can include CH3SCH3, C6HSSCH3, CH3OCH2CHZSCH3, and tetrahydrothiophene.
`-7-
`
`SUBSTITUTE SHEET (RULE 26)
`
`

`

`WO 96/04289
`
`PCT/US95I09655
`
`A neutral electron donor is any ligand which, when removed from a metal center in its closed shell
`
`electron configuration, has a neutral charge, i.e.,
`
`is a Lewis base.
`
`"halogen" or "halide", either alone or in compound words such as "haloalkyl", denotes fluorine,
`chlorine, bromine or iodine.
`
`An anionic ligand is any ligand which when removed from a metal center in its closed shell
`
`electron configuration has a negative charge. An important feature of the carbene compounds of this
`invention is the presence of the ruthenium or osmium in the formal +2 oxidation state (the carbene
`
`fragment is considered to be neutral), an electron count of l6 and pentacoordination. A wide variety of
`ligand moieties X, Xi, L, and L1 can be present and the carbene compound will still exhibit its catalytic
`activity.
`
`A preferred embodiment of the carbene compounds of the present invention is a compound of the
`invention of Formula I wherein:
`
`R and R1 are independently selected from hydrogen, vinyl, C1-C10 alkyl, aryl, Cl-Clo
`carboxylate, CZ'CIO alkoxycarbonyl, C1-C10 alkoxy, aryloxy, each optionally substituted
`with C1-C5 alkyl, halogen, C1-C5 alkoxy or with a phenyl group optionally substituted with
`halogen, C1-C5 alkyl or C1-C5 alkoxy; and
`X and XI are independently selected from halogen, hydrogen, diketonates, or Cl'CZO alkyl, aryl,
`C1-C20 alkoxide, aryloxide, C2-C20 alkoxycarbonyl, arylcarboxylate, Cl'c20 carboxylate,
`aryl or C1-C20 alkylsulfonate, C1-C20 alkylthio, C1-C20 alkylsulfonyl, C1-C20
`alkylsulfinyl, each optionally substituted with CI'CS alkyl, halogen, C1-C5 alkoxy or with a
`phenyl group optionally substituted with halogen, C1-C5 alkyl or CI'CS alkoxy; and
`L and L1 are independently selected from phosphine, sulfonated phosphine, phosphite, phosphinite,
`phosphonite, arsine, stibine, ether, amine, amide, sulfoxide, carbonyl, nitrosyl, pyridine or
`thioether.
`
`7
`
`A more preferred embodiment of the carbene compounds of the present invention is a compound of
`Formula I wherein:
`
`R and R1 are independently selected from hydrogen; vinyl, C1-C5 alkyl, phenyl, C2-C5
`alkoxycarbonyl, CI'CS carboxylate, CI'CS alkoxy, phenoxy; each optionally
`substituted with CI'CS alkyl, halogen, C1-C5 alkoxy or a phenyl group optionally
`substituted with halogen, C1-C5 alkyl or C1-C5 alkoxy;
`X and X1 are independently selected from Cl, Br, I, or benzoate, acetylacetonate, C1-C5
`carboxylate, C1-C5 alkyl, phenoxy, C1-C5 alkoxy, C1-C5 alkylthio, aryl, and C1-C5
`alkyl sulfonate; each optionally substituted with C1-C5 alkyl or a phenyl group
`optionally substituted with halogen, CI'CS alkyl or C1-C5 alkoxy; and
`L and L1 are independently selected from aryl, C1-C5 alkyl, secondary alkyl or
`cycloalkylphosphine, aryl- or CFC") alkylsulfonated phosphine, aryl or C1-C10
`alkylphosphinite, aryl- or C1-C10 alkylphosphonite, aryl- or CFC") alkylphosphite,
`aryl— or C1-C10 alkylarsine, aryl- or CFC”) alkylamine, pyridine, aryl- or C1-C10
`alkyl sulfoxide, aryl- or C1-Clo alkylether, or aryl- or C1-Clo alkylamide, each
`optionally substituted with a phenyl group optionally substituted with halogen, Cl-C5
`alkyl or C1-C5 alkoxy.
`A further preferred embodiment of the present invention is carbene compounds of Formula I wherein:
`R and R1 are independently vinyl, H, Me, Ph;
`X and X1 are independently Cl, CF3C02, CH3C02, CFHZCOZ, (CH3)3CO,
`(CF3)2(CH3)CO, (CF3) (CH3)2CO, PhO, MeO, EtO, tosylate, mesylate, or
`trifluoromethanesulfonate; and
`L and L1 are independently PPh3, P(p-Tol)3, P(o-Tol)3, PPh(Cl-l3)2, P(CF3)3, P(p-
`FC6H4)3, pyridine, P(p-CF3C6H4)3, (p-F)pyridine, (p-CF3)pyridine, P(C6H4-
`-3-
`
`10
`
`15
`
`20
`
`25
`
`30
`
`35
`
`40
`
`45
`
`SUBSTITUTE SHEET (RULE 26)
`
`

`

`WO 96/04289
`
`PCT/US95/09655
`
`SO3Na)3, P(CH2C6H4-SO3Na)3, P(iPr)3, P(CHCH3(CH2CH3))3, P(cyclopentyl)3,
`P(cyclohexyl)3, P(neopentyl)3 and P(neophenyl)3.
`For any of the foregoing described preferred groups of compounds, any 2, 3, or 4 of X, X], L, L1
`can be taken together to form a chelating multidentate ligand. Examples of bidentate ligands include, but
`
`are not limited to, bisphosphines, dialkoxides, alkyldiketonates, and aryldiketonates. Specific examples
`
`include Ph2PCH2CH2PPh2, thAsCH2CH2AsPh2, thPCHZCH2C(CF3)20‘, binaphtholate dianions,
`pinacolate dianions, Me2P(CH2)2PMe2 and 0C(CH3)2(CH3)2CO. Tridentate ligands include, but are
`not limited to, (CH )ZNCHZCHZP(Ph)Cl-12CH2N(CH3)2. Other preferred tridentate ligands are those in
`which X, L, and L are taken together to be cyclopentadienyl, indenyl or fluorenyl, each optionally
`
`substituted with C2-C20 alkenyl, C2-C20 alkynyl, C1-C20 alkyl, aryl, C1-C20 carboxylate, C1-C20
`alkoxy, C2-C20 alkenyloxy, C2-C20 alkynyloxy, aryloxy, C2-C20 alkoxycarbonyl, C1-C20 alkylthio, Cl'
`C20 alkylsulfonyl, C1-C20 alkylsulfinyl, each optionally substituted with C1-C5 alkyl, halogen, C1-C5
`alkoxy or with a phenyl group optionally substituted with halogen, C1-C5 alkyl or C1—C5 alkoxy. More
`preferably in compounds of this type, X, L, and L1 are taken together to be cyclopentadienyl or indenyl,
`
`each optionally substituted with hydrogen; vinyl, Cl’clo alkyl, aryl, C1-C10 carboxylate, CZ'CIO
`alkoxycarbonyl, C1-Clo alkoxy, aryloxy, each optionally substituted with C1-C5 alkyl, halogen, C1-C5
`alkoxy or with a phenyl group optionally substituted with halogen, C1-C5 alkyl or C1-C5 alkoxy. Most
`preferably, X, L, and L1 are taken together to be cyclopentadienyl, optionally substituted with vinyl,
`hydrogen, Me or Ph. Tetradentate ligands include, but are not limited to
`
`02C(CH2)2P(Ph)(CH2)2P(Ph)(CH2)2C02, phthalocyanines, and porphyrins.
`Carbene compounds of Formula 1 wherein L and L1 are alkyl phosphines where at least one alkyl
`group is either a secondary alkyl or a cycloalkyl. These carbene compounds have been found to be more
`stable, more reactive to nonsterically strained cyclic alkenes and unreactive to a wider variety of
`
`(Nguyen, S., et al., J. Am. Chem. Soc., 1993, m:9858-9859; Fu, 0., et 31., J. Am. Chem.
`substituents.
`m 1993, £29856-9557.)
`Specifically, carbene compounds wherein L and 1..1 are triisopropyl phosphine or tricyclohexyl
`phosphine have been found to be stable in the presence of oxygen, moisture, adventitious impurities
`
`thereby enabling reactions to be conducted in reagent grade solvents in air (Fu, 6., et al., J. Am. Chem.
`
`IO
`
`15
`
`20
`
`25
`
`30
`
`&, 1993, m:9856-9857). Further these carbenes are stable in the presence of alcohol, thiol, ketone,
`aldehyde, ester, ether, amine, amide, nitro acid, carboxylic acid, disulfide, carbonate, carboalkoxy and
`
`In addition, these carbene can catalyze olefin metathesis reactions on acyclic
`halogen functional groups.
`oleinfs and strained cyclic olefins.
`
`The most preferred carbene compounds of the present invention include:
`
`PC H
`c1\|
`ya
`nu—
`Cl/l
`PCya
`
`H
`
`Ph
`
`Ph
`
`P'PraH
`Cl\|
`__
`/Ftu
`c:
`II
`PPr3
`
`H
`
`Ph
`
`Ph
`
`wherein
`
`35
`
`iPr = isopropyl
`Cy = cyclohexyl
`
`The compounds of the present invention can be prepared in several different ways, each of which
`is described below.
`
`-9-
`
`SUBSTITUTE SHEET (RULE 26)
`
`

`

`WO 96/04289
`
`PCT/US95/09655
`
`The most general method for preparing the compounds of this invention comprises reacting
`(XXIMLnle)p with a cyclopropene or phosphoranc in the presence of a solvent to produce a carbene
`complex, as shown in the equations below:
`REACTION E UATIONS
`
`(xx'ML,,I.‘,.,)P
`
`i
`
`(xx ML..L m),
`
`1
`
`+
`
`+
`
`Ra
`
`R3
`
`__
`
`L
`x\ I = x
`
`1R
`
`,1st C\ 1
`
`R6
`
`Fl
`
`_ = —_> M:
`
`x‘/|
`
`1
`
`L
`
`\R
`
`5
`
`wherein:
`
`M, x, x‘, L, L‘, n, m, p, R2, R3, R4, R5, and R6 are as defined above. Preferably, R2, R3, R4,
`R5, and R6 are independently selected from the group consisting of C1-C6 alkyl or phenyl.
`Examples of solvents that may be used in this reaction include organic, protic, or aqueous solvents
`which are inert under the reaction conditions, such as: aromatic hydrocarbons, chlorinated hydrocarbons,
`
`10
`
`ethers, aliphatic hydrocarbons, alcohols, water, or mixtures thereof. Preferred solvents include benzene,
`
`toluene, p-xylene, methylene chloride, dichloroethane, dichlorobenzene, chlorobenzene, tetrahydrofuran,
`diethylether, pentane, methanol, ethanol, water, or mixtures thereof. More preferably, the solvent is
`benzene, toluene, p-xylene, methylene chloride, dichloroethane, dichlorobenzene, chlorobenzene,
`
`tetrahydrofuran, diethylether, pentane, methanol, ethanol, or mixtures thereof. Most preferably, the
`solvent is toluene or a mixture of benzene and methylene chloride.
`
`15
`
`A suitable temperature range for the reaction is from about -20°C to about l25°C, preferably 35°C
`to 90°C, and more preferably 50°C to 65°C. Pressure is not critical but may depend on the boiling point
`of the solvent used, i.e., sufficient pressure is needed to maintain a solvent liquid phase. Reaction times
`
`are not critical, and can be from several minutes to 48 hours. The reactions are generally carried out in
`an inert atmosphere, most preferably nitrogen or argon.
`The reaction is usually carried out by dissolving the compound (XXIMLnle)p, in a suitable
`solvent, adding the cyclopropene (preferably in a solvent) to a stirred solution of the compound, and
`optionally heating the mixture until the reaction is complete. The progress of the reaction can be
`
`monitored by any of several standard analytical techniques, such as infrared or nuclear magnetic
`resonance.
`Isolation of the product can be accomplished by standard procedures, such as evaporating the
`solvent, washing the solids (e.g., with alcohol or pentane), and then recrystallizing the desired carbene
`complex. Whether the moieties X, X], L, or L1 are (unidentate) ligands or

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket